Novel Gout Drug Aces Mid-Stage Tests

(MedPage Today) -- SAN DIEGO -- An investigational once-daily oral agent that inhibits urate transporter-1 (URAT1) as a means of forcing uric acid excretion showed good efficacy and safety in a pair of phase II trials reported here.
In one of...

Source: MedPage Today Rheumatology - November 16, 2023 Category: Rheumatology Source Type: news